This Million Targets Drug: A $7M Bet on a CNS Breakthrough
A focused look at a $7 million wager on a CNS drug maker in Phase 3. Learn what this move signals about biotech momen...
Explore a practical plan to stop overspending, reset your numbers, and build a sustainable budget that fits your income and goals.
17,082 articlesA focused look at a $7 million wager on a CNS drug maker in Phase 3. Learn what this move signals about biotech momen...
Oil spikes can move markets quickly, pushing indexes lower. Yet even with a sharp price surge, the selloff often rema...
Six Flags Entertainment drew market attention this week as activist investors nudged for strategy changes. The stock ...
Iran carried out the executions of a 19-year-old star wrestler and two others, sparking investor worry about sanction...
U.S. companies are piloting forest ‘bathing’ breaks to curb stress and improve productivity. Early results show mood ...
Oklo is building small modular reactors with a bold future. But should oklo stock while it trades under $55 be part o...
A former employee has filed a class-action complaint against US Mortgage Corp. over a May 2025 data breach that expos...
A Maryland homeowner stands accused of calling ICE on workers fixing her roof, raising serious questions about legal ...
BuildersUpdate launched a pay-on-performance marketing model, charging a $750 fee per home only when a sale closes, a...
Andreessen Horowitz's crypto unit closes its fifth fund at $2.2 billion, signaling a patient, long-horizon bet on cry...
A viral AI clip can shake trust in media and money alike. This article breaks down what happened, why it matters for ...
Financial planners warn that prioritizing 529s over retirement can jeopardize long-term security. This report explain...